Efficacy Of Intravenous Epoprostenol For Pulmonary Arterial Hypertension In 2 Treatment Eras

被引：0
|
作者：
Delcroix, M. [1 ]
Wuyts, W. [1 ]
Vandevelde, E. [1 ]
Koen, J. [2 ]
De Clippel, M. [3 ]
Baptista, R. [3 ]
Vachiery, J. -L. [3 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] GSK Phamaceut, Wavre, Belgium
[3] Erasme Univ Hosp, Brussels, Belgium
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3284
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravenous epoprostenol therapy in the treatment of pulmonary arterial hypertension in Singapore
    Choo, Jack
    Yap, Jonathan
    Ismail, Aidila
    Hon, Jin Shing
    Ruan, Wen
    Low, Andrea
    Lim, Soo Teik
    Tan, Ju Le
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2024, 53 (10) : 627 - 631
  • [2] Intravenous epoprostenol therapy in the treatment of pulmonary arterial hypertension: the Singapore experience
    Choo, J.
    Yap, J.
    Aidila, Ismail
    Lim, C. L.
    Sumathy, P.
    Ruan, W.
    Sewa, D. W.
    Phua, G. C.
    Hong, C.
    Low, A. H. L.
    Lim, S. T.
    Tan, J. L.
    EUROPEAN HEART JOURNAL, 2022, 43
  • [3] THERMOSTABLE INTRAVENOUS EPOPROSTENOL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - A TRANSITION STUDY
    MacLellan, A.
    Carson, K.
    Brewis, M.
    Johnson, M.
    McGettrick, M.
    McCaughey, P.
    Crozier, A.
    Thomson, R.
    Church, C.
    THORAX, 2019, 74 : A152 - A153
  • [4] Epoprostenol for the treatment of pulmonary arterial hypertension
    Cristo Ropero, Maria Jose
    Cruz-Utrilla, Alejandro
    Pilar Escribano-Subias, Maria
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (08) : 1005 - 1013
  • [5] Urticaria induced by continuous intravenous epoprostenol treatment in a patient with pulmonary arterial hypertension
    Sawada, Tomoya
    Kuwai, Takumi
    Nakajima, Saeko
    Chen-Yoshikawa, Toyofumi Fengshi
    Nomura, Takashi
    Date, Hiroshi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2024, 51 (12): : e431 - e432
  • [6] Epoprostenol sodium for treatment of pulmonary arterial hypertension
    Saito, Yukihiro
    Nakamura, Kazufumi
    Akagi, Satoshi
    Sarashina, Toshihiro
    Ejiri, Kentaro
    Miura, Aya
    Ogawa, Aiko
    Matsubara, Hiromi
    Ito, Hiroshi
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 265 - 270
  • [7] Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
    Mohammadi, Asma
    Matos, Wanessa F.
    Intriago, Cesar
    Thakkar, Keval
    Jahan, Nasrin
    Shah, Heeya
    Nishu, Rifath I.
    Marzban, Sima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [8] Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
    Timofeev, Julia
    Ruiz, George
    Fries, Melissa
    Driggers, Rita W.
    AJP REPORTS, 2013, 3 (02): : 71 - 74
  • [9] Efficacy and limitations of continuous intravenous Epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children
    Nakayama, Tomotaka
    Shimada, Hiromitsu
    Takatsuki, Shinichi
    Hoshida, Hiroshi
    Ishikita, Takashi
    Matsuura, Hiroyuki
    Saji, Tsutomu
    CIRCULATION JOURNAL, 2007, 71 (11) : 1785 - 1790
  • [10] Epoprostenol in pulmonary arterial hypertension
    Jacobs, Wouter
    Vonk-Noordegraaf, Anton
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (01) : 83 - 90
12345